Situational Analysis of the Medicine Evaluation and Registration System of Afghanistan
(2012; 67 pages)

  • Wahidullah Karwar SCS Senior Technical Advisor, SPS Afghanistan
  • Mohammad Zafar Omari Chief of Party, SPS Afghanistan
  • Ahmad Farid Sarwary Regulation/Legal Officer, SPS Afghanistan
  • Mohammad Basir Regulation/Legal Officer, SPS Afghanistan
  • Mark Morris, Deputy Chief of Party, SPS Afghanistan
  • Luther Gwaza SPS Regulatory Consultant, Zimbabwe
  • Shiou-Chu Judy Wang, SPS Senior Program Associate, Arlington Washington
  • David Lee,Director for Technical Strategy and Quality, Center for Pharmaceutical Management, Arlington Washington

Situational Analysis of the Medicine Evaluation and Registration System of Afghanistan Submitted to the U.S. Agency for International Development by the Strengthening Pharmaceutical Systems (SPS) Associate Award Program. Arlington, VA: Management Sciences for Health.

Abstract

The overall objective of the assessment is to ensure that medicines available on the market in Afghanistan are properly evaluated and registered or licensed in terms of safety, efficacy, and quality.

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018